Molecular Cancer Therapeutics

Molecular Cancer Therapeutics is a journal of the American Association for Cancer Research that publishes research on molecular targets and the development of therapeutic agents for cancer, with a 2025 Journal Impact Factor of 6.9《分子癌症治疗学》（Molecular Cancer Therapeutics）是美国癌症研究协会的期刊，发表关于分子靶点与抗癌治疗药物开发的研究，2025 年影响因子为 6.9;}-

Scope

• The journal covers molecular targets and therapeutic agents for cancer该刊覆盖癌症的分子靶点与治疗药物;}-
• Preclinical development of novel anticancer drugs is central新型抗癌药物的临床前开发是核心;}-
• Studies of drug targets, mechanisms of action and resistance are published药物靶点、作用机制与耐药性研究均在发表之列;}-
• Biomarkers and pharmacodynamic endpoints are recurring subjects生物标志物与药效学终点是常见主题;}-
• Translational work linking laboratory findings to clinical testing is emphasised强调把实验室发现与临床检验相衔接的转化研究;}-
• Combination strategies and therapeutic antibodies are within scope联合治疗策略与治疗性抗体亦在其范围;}-

History

• The journal was established in 2001 by the American Association for Cancer Research该刊 2001 年由美国癌症研究协会创办;}-
• It is published monthly in Philadelphia by the association期刊由该协会在费城按月出版;}-
• The journal is published by American Association for Cancer Research and appears monthly, under print ISSN 1535-7163, electronic ISSN 1538-8514该刊由（American Association for Cancer Research）出版，按月刊出版，印刷 ISSN 为 1535-7163，电子 ISSN 为 1538-8514。;}-
• Its Journal Impact Factor was 6.261 in 2021 and reached 6.9 in 2025, with the reported series 6.9, 5.5, 6.009, 6.261其影响因子由 2025 年的 6.9、2024 年的 5.5、2022 年的 6.009、2021 年的 6.261 等年度数据构成，最新为 2025 年的 6.9。

Editors

• The editorial board is drawn from academic and clinical cancer research institutions编委会成员来自学术与临床癌症研究机构
• It is indexed in the Science Citation Index Expanded, MEDLINE and Scopus该刊被（Science Citation Index Expanded）、（MEDLINE）与（Scopus）收录。;}-